“Ligand-based drug design studies of different flavonoids as a potential inhibitor of BCR-ABL”, UCP J. Sci. Technol., vol. 3, no. 1, pp. 29–45, Dec. 2025, doi: 10.24312/ucp-jst.03.01.704.